Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States.
Saved in:
| Title: | Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States. |
|---|---|
| Authors: | Danpanichkul P; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA., Duangsonk K; Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Kalligeros M; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Fallon MB; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA.; Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA., Vuthithammee C; Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Pan CW; Department of Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA., Saokhieo P; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Derrick W; Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas, USA., Pang Y; Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.; National Immunological Laboratory of Traditional Chinese Medicine, Baise, Guangxi, China.; Center for Medical Laboratory Science, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China., Chen VL; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA., Kim D; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA., Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Yang JD; Karsh Division of Gastroenterology and Hepatology, Comprehensive Transplant Center, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, California, Los Angeles, USA., Wijarnpreecha K; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA.; Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA.; BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2025 Mar; Vol. 61 (6), pp. 959-970. Date of Electronic Publication: 2025 Jan 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
